arrow
H

Heimo Lagler

university of munich
H指数:27
被引数:2,410

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ergosterol-depleted clinical isolates of Nakaseomyces glabratus can develop multi-drug resistance without severe fitness defects or attenuated virulence in an invertebrate infection model

胶红酵母临床分离株中缺乏麦角甾醇可发展出多药耐药性,而未在无脊椎动物感染模型中引起严重的适应性缺陷或毒力减弱

mBio
IF4.7
2026-05-010
PRE
Clinical and Parasitological Characteristics of Plasmodium vivax Malaria in Malaria-Naïve Patients: A Review of Malaria Fever Therapy in Patients with Schizophrenia and Neurosyphilis during the 1950s and 1960s in Vienna, Austria

间日疟原虫疟疾的临床和寄生虫学特征:对1950年代和1960年代在奥地利维也纳精神分裂症和神经梅毒患者中疟疾发热疗法的回顾

2025-12-010
PRE
Unveiling the incidences and trends of alveolar echinococcosis in Europe: a systematic review from the KNOW-PATH project

揭示欧洲肺泡棘球蚴病的发病情况和趋势:KNOW-PATH项目的一项系统综述

2025-06-240
PRE
Unraveling novel mutation patterns and morphological variations in two dalbavancin-resistant MRSA strains in Austria using whole genome sequencing and transmission electron microscopy
2024-09-022
OAAI
Prevalence and clinical implications of bloodstream infections in intensive care patients with or without burn injury: a retrospective cohort study

有或没有烧伤的重症监护患者血流感染的患病率和临床意义: 一项回顾性队列研究

2024-06-261
OAAI
Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial
2024-05-019
PRE
Differences in oxazolidinone resistance mechanisms and small colony variants emergence of Staphylococcus aureus induced in an in vitro resistance development model

在体外耐药发展模型中诱导的金黄色葡萄球菌恶唑烷酮耐药机制和小菌落变异出现的差异

2024-02-060
OAAI
Evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women: a multi-centre, double-blind, placebo-controlled trial (MAMAH project)
2023-12-170
OA
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in a randomized, double-blind, placebo-controlled Phase 2 trial

在一项随机,双盲,安慰剂对照的2期试验中,局部用氯硝柳胺 (ATx201) 可减少特应性皮炎患者金黄色葡萄球菌定植并增加皮肤微生物组的Shannon多样性

2022-05-0621
OAAI